Abstract
In present brief review we discussed the underlying reasons for the negative results of international clinical trials in the field of Critical Care Medicine. Since there is a huge heterogeneity among the patients with sepsis or acute respiratory distress syndrome (ARDS) who are recruited in the studies, it is resonable that none of strategy could be fit to all condition no matter medical resource distribution and geographic location. Therefore, it becomes to be nightmare for the researchers as the primary outcome, mortality, is hard to be improved. Only when realizing and resloving above situation, especially the disadvantage of definition of Sepsis and ARDS, could the future large trial be successful. Key words: Critical Care Medicine; Clinical trial; Sepsis; Acute respiratory distress syndrom; heterogeneity; Negative
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
